178 related articles for article (PubMed ID: 9101640)
21. Important determinants for fucoidan bioactivity: a critical review of structure-function relations and extraction methods for fucose-containing sulfated polysaccharides from brown seaweeds.
Ale MT; Mikkelsen JD; Meyer AS
Mar Drugs; 2011; 9(10):2106-2130. PubMed ID: 22073012
[TBL] [Abstract][Full Text] [Related]
22. The association of depression with platelet activation: evidence for a treatment effect.
Morel-Kopp MC; McLean L; Chen Q; Tofler GH; Tennant C; Maddison V; Ward CM
J Thromb Haemost; 2009 Apr; 7(4):573-81. PubMed ID: 19192119
[TBL] [Abstract][Full Text] [Related]
23. [Sulfated polysaccharides and their anticoagulant activity (review)].
Mestechkina NM; Shcherbukhin VD
Prikl Biokhim Mikrobiol; 2010; 46(3):291-8. PubMed ID: 20586281
[TBL] [Abstract][Full Text] [Related]
24. Sulfated galactofucan from Lobophora variegata: anticoagulant and anti-inflammatory properties.
Medeiros VP; Queiroz KC; Cardoso ML; Monteiro GR; Oliveira FW; Chavante SF; Guimaraes LA; Rocha HA; Leite EL
Biochemistry (Mosc); 2008 Sep; 73(9):1018-24. PubMed ID: 18976219
[TBL] [Abstract][Full Text] [Related]
25. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.
van der Zee PM; Biró E; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R
Clin Chem; 2006 Apr; 52(4):657-64. PubMed ID: 16439610
[TBL] [Abstract][Full Text] [Related]
26. Preparation of aminated fucoidan and its evaluation as an antithrombotic and antilipemic agent.
Soeda S; Ohmagari Y; Shimeno H; Nagamatsu A
Biol Pharm Bull; 1994 Jun; 17(6):784-8. PubMed ID: 7951138
[TBL] [Abstract][Full Text] [Related]
27. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules.
Konijnenberg A; Stokkers EW; van der Post JA; Schaap MC; Boer K; Bleker OP; Sturk A
Am J Obstet Gynecol; 1997 Feb; 176(2):461-9. PubMed ID: 9065199
[TBL] [Abstract][Full Text] [Related]
28. Prolonged holding of whole blood at 22 degrees C does not increase activation in platelet concentrates.
Sanz C; Pereira A; Faúndez AI; Ordinas A
Vox Sang; 1997; 72(4):225-8. PubMed ID: 9228712
[TBL] [Abstract][Full Text] [Related]
29. Platelet activation markers in patients with nephrotic syndrome. A comparative study of different platelet function tests.
Sirolli V; Ballone E; Garofalo D; Merciaro G; Settefrati N; Di Mascio R; Di Gregorio P; Bonomini M
Nephron; 2002 Jul; 91(3):424-30. PubMed ID: 12119472
[TBL] [Abstract][Full Text] [Related]
30. High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy.
Kéreveur A; Callebert J; Humbert M; Hervé P; Simonneau G; Launay JM; Drouet L
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2233-9. PubMed ID: 11031209
[TBL] [Abstract][Full Text] [Related]
31. A disaccharide repeat unit is the major structure in fucoidans from two species of brown algae.
Chevolot L; Mulloy B; Ratiskol J; Foucault A; Colliec-Jouault S
Carbohydr Res; 2001 Feb; 330(4):529-35. PubMed ID: 11269406
[TBL] [Abstract][Full Text] [Related]
32. Platelet-derived growth factor inhibits platelet activation in heparinized whole blood.
Selheim F; Holmsen H; Vassbotn FS
Thromb Res; 1999 Aug; 95(4):185-96. PubMed ID: 10498388
[TBL] [Abstract][Full Text] [Related]
33. The dopamine agonism on ADP-stimulated platelets is mediated through D2-like but not D1-like dopamine receptors.
Schedel A; Schloss P; Klüter H; Bugert P
Naunyn Schmiedebergs Arch Pharmacol; 2008 Oct; 378(4):431-9. PubMed ID: 18542926
[TBL] [Abstract][Full Text] [Related]
34. Course of platelet activation markers after ischemic stroke.
Marquardt L; Ruf A; Mansmann U; Winter R; Schuler M; Buggle F; Mayer H; Grau AJ
Stroke; 2002 Nov; 33(11):2570-4. PubMed ID: 12411644
[TBL] [Abstract][Full Text] [Related]
35. Physicochemical characterization of Sargassum fusiforme fucoidan fractions and their antagonistic effect against P-selectin-mediated cell adhesion.
Wu S; Zhang X; Liu J; Song J; Yu P; Chen P; Liao Z; Wu M; Tong H
Int J Biol Macromol; 2019 Jul; 133():656-662. PubMed ID: 30930270
[TBL] [Abstract][Full Text] [Related]
36. Platelet activation markers and the primary antiphospholipid syndrome (PAPS).
Joseph JE; Harrison P; Mackie IJ; Machin SJ
Lupus; 1998; 7 Suppl 2():S48-51. PubMed ID: 9814673
[TBL] [Abstract][Full Text] [Related]
37. Platelet aggregates as markers of platelet activation: characterization of flow cytometric method suitable for clinical applications.
Jy W; Horstman LL; Park H; Mao WW; Valant P; Ahn YS
Am J Hematol; 1998 Jan; 57(1):33-42. PubMed ID: 9423814
[TBL] [Abstract][Full Text] [Related]
38. In vitro comparison study of CD63 and CD62P expression after contacting leukocyte filters.
Fukunaga K; Shimoyama T; Yamaji K; Yamane S; Sueoka A; Nosé Y
Artif Organs; 1999 Jan; 23(1):108-13. PubMed ID: 9950188
[TBL] [Abstract][Full Text] [Related]
39. Anticoagulant-induced pseudothrombocytopenia and pseudoleucocytosis.
Schrezenmeier H; Müller H; Gunsilius E; Heimpel H; Seifried E
Thromb Haemost; 1995 Mar; 73(3):506-13. PubMed ID: 7545322
[TBL] [Abstract][Full Text] [Related]
40. A fluorescence-conjugated immunobinding assay for the detection of P-selectin on platelets.
Wen D; Nguyen TT; Plumhoff EA; Pineda AA; Bowie EJ; Kottke BA
J Lab Clin Med; 1994 Sep; 124(3):447-54. PubMed ID: 7521896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
